Orilissa (elagolix) / Neurocrine, AbbVie  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Orilissa (elagolix) / AbbVie
GRACE, NCT04080856: Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada

Completed
N/A
100
Canada
AbbVie
Endometriosis
09/21
09/21
ENDORSE, NCT04630990: Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain

Completed
N/A
117
RoW
AbbVie
Endometriosis
03/24
03/24
NCT04464187: A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules

Terminated
N/A
173
US
AbbVie
Endometriosis, Uterine Fibrioids
07/25
07/25

Download Options